SIOC English
有机化学
高级检索

有机化学 >

2020 , Vol. 40 >Issue 2: 376 - 383

DOI: https://doi.org/10.6023/cjoc201907053

研究论文

通过不对称氢转移/动态动力学拆分合成碳环N3-嘌呤核苷

  • 张齐英 ,
  • 张一铭 ,
  • 郝二军 ,
  • 白娟 ,
  • 渠桂荣 ,
  • 郭海明
展开
  • 河南师范大学化学化工学院 绿色化学介质与反应教育部重点实验室 精细化学品绿色制造河南省协同创新中心 河南省有机功能分子与药物创新重点实验室 河南新乡 453007

收稿日期: 2019-07-30

  修回日期: 2019-09-30

  网络出版日期: 2019-10-25

基金资助

国家自然科学基金（Nos.21602045，U1604283）和高等学校学科创新引智计划（111计划，No.D17007）资助项目.

收起

Asymmetric Transfer Hydrogenation via Dynamic Kinetic Resolution for the Construction of Carbocyclic N3-Purine Nucleosides

  • Zhang Qiying ,
  • Zhang Yiming ,
  • Hao Erjun ,
  • Bai Juan ,
  • Qu Guirong ,
  • Guo Haiming
Expand
  • Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007

Received date: 2019-07-30

  Revised date: 2019-09-30

  Online published: 2019-10-25

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21602045, U1604283), and the Overseas Expertise Introduction Project for Discipline Innovation (111 Project, No. D17007).

Fold

摘要

N3-嘌呤核苷由于可能同时被嘌呤和嘧啶代谢酶识别，因而有望作为双靶点药物应用于抗病毒治疗.报道了一种以α-（N3-嘌呤）取代的环烷酮为原料，通过不对称氢转移反应实现动态动力学拆分，高收率高立体选择性地合成系列碳环N3-嘌呤核苷化合物.该催化体系也适用于α-嘧啶取代的环烷酮底物，且产物通过进一步衍生，合成了2'-F-，AcS-，N3-修饰的碳环嘧啶核苷.

关键词： 碳环核苷; 双靶点抑制剂; 动态动力学拆分; 不对称氢转移反应

本文引用格式

张齐英 , 张一铭 , 郝二军 , 白娟 , 渠桂荣 , 郭海明 . 通过不对称氢转移/动态动力学拆分合成碳环N3-嘌呤核苷[J]. 有机化学, 2020 , 40(2) : 376 -383 . DOI: 10.6023/cjoc201907053

Abstract

N3-Purine nucleoside can be employed as a potent dual inhibitor to inhibit viruses more effectively because it could be possibly recognized by both purine-and pyrimidine-metabolizing enzymes. Herein, an asymmetric transfer hydrogenation via dynamic kinetic resolution of rac-α-(purin-3-yl)cyclopentones has been developed to produce a wide range of carbocyclic N3-purine nucleosides in high yields and excellent stereoselectivities. Moreover, the catalytic system was suitable for rac-α-pyrimidinyl cyclopentones. With additional transformations, several 2'-F-, AcS-, N3-modified carbocyclic nucleosides could be obtained with good to excellent yields and excellent enantioselectivities.

Key words： carbocyclic nucleosides; dual inhibitors; dynamic kinetic resolution; asymmetric transfer hydrogenation

参考文献

[1] (a) Zhou, H.; Zeng, X.; Ding, L.; Xie, Y.; Zhong, G. Org. Lett. 2015, 17, 2385.
(b) Trost, B. M.; Madsen, R.; Guile, S. D.; Brown, B. J. Am. Chem. Soc. 2000, 122, 5947.
(c) Kakuda, T. N. Clin. Ther. 2000, 22, 685.
(d) Boutureira, O.; Matheu, M. I.; Díaz, Y.; Castillón, S. Chem. Soc. Rev. 2013, 42, 5056.
(e) Forsman, J. J.; Leino, R. Chem. Rev. 2011, 111, 3334.
(f) Lebreton, J.; Escudier, J.-M.; Arzel, Len, C. Chem. Rev. 2010, 110, 3371.
(g) Amblard, F.; Cho, J. H.; Schinazi, R. F. Chem. Rev. 2009, 109, 4207.
(h) Liu, Y.; Guo, X.; Bai, P. Chin. J. Org. Chem. 2014, 34, 2202(in Chinese). (刘亚君, 郭翔海, 白鹏, 有机化学, 2014, 34, 2202.)
(i) Fan, X.-S; Zhang, X.-Y.; Wang, X.; Qu, G.-R. Chin. J. Org. Chem. 2008, 28, 1888(in Chinese). (范学森, 张新迎, 王霞, 渠桂荣, 有机化学, 2008, 28, 1888.)
[2] (a) Barral, K.; Courcambeck, J.; Pèpe, G.; Balzarini, J.; Neyts, J.; Clercq, E. D.; Camplo, M. J. Med. Chem. 2005, 48, 450.
(b) Keane, S. J.; Ford, A.; Mullins, N. D.; Maguire, N. M.; Legigan, T.; Balzarini, J.; Maguire, A. R. J. Org. Chem. 2015, 80, 2479.
(c) Gai, X.; Song, W.; Heng, S.; Yang, W. Chin. J. Integr. Tradit. West. Med. Liver Dis. 2005, 15, 50(in Chinese). (盖欣, 宋万玲, 桓树学, 杨文东, 中西医结合肝病杂志, 2005, 15, 50.)
[3] (a) Hu, L.; Ren, Y.; Ramström, O. J. Org. Chem. 2015, 80, 8478.
(b) Singh, U. S.; Mishra, R. C.; Shankar, R.; Chu, C. K. J. Org. Chem. 2014, 79, 3917.
(c) Caso, M. F.; D'Alonzo, D.; D'Errico, S.; Palumbo, G.; Guaragna, A. Org. Lett. 201517, 2626.
[4] (a) Silverman, R. B. The Organic Chemistry of Drug Design and Drug Action, Elsevier, Evanston, 2004.
(b) Kompis, I. M.; Islam, K.; Then, R. L. Chem. Rev. 2005, 105, 583.
(c) Lyon, M. A.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Nat. Rev. Drug Disc. 2002, 1, 961.
(d) Gangjee, A.; Li, W.; Yang, J.; Kisliuk, R. L. J. Med. Chem. 2008, 51, 68.
[5] (a) Jeong, L. S.; Lee, J. A. Antiviral Chem. Chemother. 2004, 15, 235.
(b) Liu, Y.; Guo, X.; Bai, P. Chin. J. Org. Chem. 2014, 34, 2202.
(c) Boutureira, O.; Matheu, M. I.; Díaz, Y.; Castillón, S. Chem. Soc. Rev. 2013, 42, 5056.
[6] (a) Xie, M.-S.; Wang, Y.; Li, J.-P.; Du, C.; Zhang, Y.-Y.; Hao, E.-J.; Zhang, Y.-M.; Qu, G.-R.; Guo, H.-M. Chem. Commun. 2015, 51, 12451.
(b) Huang, K.-X.; Xie, M.-S.; Zhang, Q.-Y.; Niu, H.-Y.; Qu, G.-R.; Guo, H.-M. Org. Lett. 2018, 20, 5398.
(c) Wang, J.; Zhang, Q.-Y.; Xie, M.-S.; Wang, D.-C.; Qu, G.-R.; Guo, H.-M. Org. Lett. 2018, 20, 6578.
(d) Gao, Y.-W.; Niu, H.; Zhang, Q.-Y.; Xie, M.; Qu, G.; Guo, H. Adv. Synth. Catal. 2018, 360, 2813.
[7] (a) Bhat, B.; Neelima, N. J.; Leonard, H.; Robinson, A.; Wang, H.-J. J. Am. Chem. Soc. 1996, 118, 3065.
(b) Leonard, N. J.; Laursenf, R. A. Biosci., Biotechnol., Biochem. 1965, 4, 354.
[8] (a) Sadler, J. M.; Mosley, S. L.; Dorgan, K. M.; Zhou, Z. S.; Seley-Radtke, K. L. Bioorg. Med. Chem. 2009, 17, 5520.
(b) Jiang, M. X.-W.; Warshakoon, N. C.; Miller, M. J. J. Org. Chem. 2005, 70, 2824.
[9] (a) Tang, W.; Zhang, X. Chem. Rev. 2003, 103, 3029.
(b) Liu, S.; Xie, J.-H.; Wang, L.-X.; Zhou, Q.-L. Angew. Chem. 2007, 119, 7650; Angew. Chem., Int. Ed. 2007, 46, 7506.
(c) Liu, S.; Xie, J.-H.; Li, W.; Kong, W.-L.; Wang, L.-X.; Zhou, Q.-L. Org. Lett. 2009, 11, 4994.
(d) Zhou, Q.; Xie, J.; Zhu, S.; Wang, L. Tianjin Sci. Technol. 2014, 41, 11(in Chinese). (周其林, 谢建华, 朱守非, 王立新, 天津科技, 2014, 41, 11.)
[10] (a) Zhang, Q.; Ma, B.-W.; Wang, Q.-.Q.; Wang, X.-X.; Hu, X.; Xie, M.-S.; Qu, G.-R.; Guo, H.-M. Org. Lett. 2014, 16, 2014.
(b) Vyas, V. K.; Bhanage, B. M. Org. Lett. 2016, 18, 6436.
(c) Matsunami, A.; Ikeda, M.; Nakamura, H.; Yoshida, M.; Kuwata, S.; Kayaki, Y. Org. Lett. 2018, 20, 5213.
(d) Vyas, V. K.; Bhanage, B. M. Asian J. Org. Chem. 2018, 7, 346.
(e) Liu, Q.; Wang, C.; Zhou, H.; Wang, O.; Lv, J.; Cao, Lu; Fu, Y. Org. Lett. 2018, 20, 971.
[11] (a) Zhang, Y.-M.; Zhang, Q.-Y.; Wang, D.-C.; Xie, M.-S.; Qu, G.-R.; Guo, H.-M. Org. Lett. 2019, 21, 2998.
(b) Sun, H.-L.; Chen, F.; Xie, M.-S.; Guo, H.-M.; Qu, G.-R.; He, Y.-M.; Fan, Q.-H. Org. Lett. 2016, 18, 2260.
[12] (a) Chan, A. S. C.; Pluth, J. J.; Halpern, J. J. Am. Chem. Soc. 1980, 102, 5952.
(b) Miyashita, A.; Yasuda, A.; Takaya, H.; Toriumi, K.; Ito, T.; Souchi, T.; Noyori, R. J. Am. Chem. Soc. 1980, 102, 7932.
Options
文章导航

/

〈 〉